| scholarly article | Q13442814 |
| P50 | author | Anna Kristina Serquina | Q55292854 |
| P2093 | author name string | Chia-Ying Chu | |
| Tariq M Rana | |||
| Hong Cao | |||
| Chih-Chung Lu | |||
| Robin Nathans | |||
| P2860 | cites work | Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies | Q21090536 |
| Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54 | Q21146051 | ||
| Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element | Q22242847 | ||
| MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies | Q24681266 | ||
| Changes in microRNA expression profiles in HIV-1-transfected human cells | Q25257532 | ||
| Interferon modulation of cellular microRNAs as an antiviral mechanism | Q27489711 | ||
| Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | Q27860488 | ||
| The functions of animal microRNAs | Q27860621 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 | ||
| Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies | Q28252216 | ||
| Inhibition of translational initiation by Let-7 MicroRNA in human cells | Q28265842 | ||
| P bodies: at the crossroads of post-transcriptional pathways | Q28280058 | ||
| Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients | Q28284190 | ||
| MicroRNA biogenesis: coordinated cropping and dicing | Q29547496 | ||
| Control of translation and mRNA degradation by miRNAs and siRNAs | Q29614239 | ||
| A cellular microRNA mediates antiviral defense in human cells | Q29615828 | ||
| Illuminating the silence: understanding the structure and function of small RNAs | Q29622905 | ||
| RNA helicase A interacts with RISC in human cells and functions in RISC loading | Q30179451 | ||
| HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR | Q33292464 | ||
| Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. | Q33635863 | ||
| The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates | Q33884059 | ||
| MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs | Q34593731 | ||
| Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes | Q34695803 | ||
| Viruses and microRNAs | Q36493262 | ||
| Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency | Q36535608 | ||
| Small RNAs: regulators and guardians of the genome | Q36901053 | ||
| Identification of human microRNA targets from isolated argonaute protein complexes | Q40105925 | ||
| Suppression of microRNA-silencing pathway by HIV-1 during virus replication | Q40166750 | ||
| Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization | Q40493589 | ||
| P433 | issue | 6 | |
| P921 | main subject | HIV | Q15787 |
| microRNA | Q310899 | ||
| P304 | page(s) | 696-709 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | Cellular microRNA and P bodies modulate host-HIV-1 interactions | |
| P478 | volume | 34 |
| Q40801549 | A Bioinformatics Method for the Design of Live Attenuated Virus Vaccine Utilizing Host MicroRNA Response Elements. |
| Q33842068 | A candidate approach implicates the secreted Salmonella effector protein SpvB in P-body disassembly |
| Q34529556 | A computational tool for the design of live attenuated virus vaccine based on microRNA-mediated gene silencing |
| Q34494556 | A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration |
| Q36989920 | A plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease |
| Q33840754 | A re-examination of global suppression of RNA interference by HIV-1. |
| Q34426498 | A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages |
| Q34868689 | APOBEC3 inhibits DEAD-END function to regulate microRNA activity |
| Q38286147 | APOBEC3G complexes decrease human immunodeficiency virus type 1 production |
| Q36299884 | Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophages |
| Q64983166 | Aedes aegypti microRNA, miR-2944b-5p interacts with 3'UTR of chikungunya virus and cellular target vps-13 to regulate viral replication. |
| Q34079328 | Ago-2-mediated slicer activity is essential for anti-flaviviral efficacy of RNAi |
| Q28308235 | Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family |
| Q37816443 | Analysis of the roles of HIV-derived microRNAs |
| Q40692790 | Anti-HIV microRNA expression in a novel Indian cohort |
| Q36870444 | Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology |
| Q37904339 | Antiviral effects of human microRNAs and conservation of their target sites |
| Q38242934 | Antiviral innate immunity and stress granule responses |
| Q52671487 | Are microRNAs Important Players in HIV-1 Infection? An Update. |
| Q33580330 | Argonaute proteins regulate HIV-1 multiply spliced RNA and viral production in a Dicer independent manner |
| Q92662206 | Assessing the Potential Interactions between Cellular miRNA and Arboviral Genomic RNA in the Yellow Fever Mosquito, Aedes aegypti |
| Q90594756 | Barriers for HIV Cure: The Latent Reservoir |
| Q64083383 | Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies |
| Q36297954 | Cellular miR-130b inhibits replication of porcine reproductive and respiratory syndrome virus in vitro and in vivo |
| Q35069646 | Cellular microRNA miR-181b inhibits replication of mink enteritis virus by repression of non-structural protein 1 translation |
| Q36364322 | Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1. |
| Q40107354 | DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes |
| Q38208676 | DDX6 and its orthologs as modulators of cellular and viral RNA expression |
| Q33510824 | Decoding the multifaceted HIV-1 virus-host interactome |
| Q37127522 | Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development |
| Q37738718 | Difference in microRNA expression and editing profile of lung tissues from different pig breeds related to immune responses to HP-PRRSV. |
| Q51052248 | Distinct DDX DEAD-box RNA helicases cooperate to modulate the HIV-1 Rev function. |
| Q24299125 | Distinct functions of maternal and somatic Pat1 protein paralogs |
| Q36727541 | Diversion of stress granules and P-bodies during viral infection |
| Q35932258 | EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency |
| Q26775176 | Emerging Roles for MicroRNAs in Perioperative Medicine |
| Q55309857 | Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference. |
| Q33927772 | Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection |
| Q37950301 | Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system |
| Q39712159 | Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction |
| Q37955258 | Evaluation of online miRNA resources for biomedical applications. |
| Q42326718 | Evidence for miRNA expression differences of HIV-1-positive, treatment-naive patients and elite suppressors: a re-analysis |
| Q36211443 | Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction. |
| Q42705630 | First Evidence for the Disease-Stage, Cell-Type, and Virus Specificity of microRNAs during Human Immunodeficiency Virus Type-1 Infection |
| Q33535836 | Five questions about viruses and microRNAs |
| Q41307773 | Flow Cytometric Characterization of Antigen-Specific T Cells Based on RNA and Its Advantages in Detecting Infections and Immunological Disorders |
| Q34775636 | Function of a retrotransposon nucleocapsid protein |
| Q63741188 | Functional Interplay between RNA Viruses and Non-Coding RNA in Mammals |
| Q33862780 | GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity |
| Q33950298 | Genome-wide screening using RNA interference to study host factors in viral replication and pathogenesis |
| Q89694033 | HIV infection suppresses TLR3 activation-mediated antiviral immunity in microglia and macrophages |
| Q34291663 | HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly |
| Q35726813 | HIV-1 RNAs are Not Part of the Argonaute 2 Associated RNA Interference Pathway in Macrophages |
| Q35562611 | HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. |
| Q34167213 | HIV-1 host interactions: integration of large-scale datasets |
| Q24297395 | HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies |
| Q34516541 | HIV-1 suppressive sequences are modulated by Rev transport of unspliced RNA and are required for efficient HIV-1 production |
| Q36976156 | HIV-1 transcription and latency: an update |
| Q26866444 | HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status |
| Q90088015 | Hepatitis B virus X protein enhances hepatocarcinogenesis by depressing the targeting of NUSAP1 mRNA by miR-18b |
| Q37481988 | Hepatitis C Virus and HIV Type 1 Co-Infection |
| Q35127629 | Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. |
| Q36245718 | Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages |
| Q38711900 | High-throughput sequencing identifies HIV-1-replication- and latency-related miRNAs in CD4+ T cell lines |
| Q28595106 | Host Range Restriction of Insect-Specific Flaviviruses Occurs at Several Levels of the Viral Life Cycle |
| Q37220761 | Host genes associated with HIV/AIDS: advances in gene discovery |
| Q36548179 | Host restriction factors in retroviral infection: promises in virus-host interaction |
| Q54260280 | Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages. |
| Q42424730 | Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus |
| Q37382519 | Human cellular restriction factors that target HIV-1 replication |
| Q33863026 | Human immunodeficiency virus Tat associates with a specific set of cellular RNAs |
| Q36827356 | Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome |
| Q35785525 | IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection |
| Q37655340 | Identification of miRNA-mRNA crosstalk in CD4+ T cells during HIV-1 infection by integrating transcriptome analyses |
| Q36039259 | Identification of the MicroRNA Repertoire in TLR-Ligand Challenged Bubaline PBMCs as a Model of Bacterial and Viral Infection |
| Q52319021 | Identifying the assembly intermediate in which Gag first associates with unspliced HIV-1 RNA suggests a novel model for HIV-1 RNA packaging. |
| Q92511221 | Illuminating the Role of Vpr in HIV Infection of Myeloid Cells |
| Q36790808 | In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. |
| Q36559629 | Increasing expression of microRNA 181 inhibits porcine reproductive and respiratory syndrome virus replication and has implications for controlling virus infection. |
| Q38720879 | Induced Packaging of Cellular MicroRNAs into HIV-1 Virions Can Inhibit Infectivity |
| Q28390469 | Influence of Aspergillus fumigatus conidia viability on murine pulmonary microRNA and mRNA expression following subchronic inhalation exposure |
| Q34756351 | Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes |
| Q34561070 | Insights into cellular factors that regulate HIV-1 replication in human cells |
| Q34315034 | Integrated analysis of microRNA expression and mRNA transcriptome in lungs of avian influenza virus infected broilers. |
| Q38475595 | Integrated miRNA and mRNA transcriptomes of porcine alveolar macrophages (PAM cells) identifies strain-specific miRNA molecular signatures associated with H-PRRSV and N-PRRSV infection. |
| Q26781552 | Interaction of drugs of abuse and microRNA with HIV: a brief review |
| Q28078564 | Interactions between the HIV-1 Unspliced mRNA and Host mRNA Decay Machineries |
| Q92152935 | Interferon-Inducible MicroRNA miR-128 Modulates HIV-1 Replication by Targeting TNPO3 mRNA |
| Q37799601 | Interferons and MicroRNAs |
| Q35823730 | Interplay between HIV-1 infection and host microRNAs |
| Q33887767 | Intestinal epithelial barrier disruption through altered mucosal microRNA expression in human immunodeficiency virus and simian immunodeficiency virus infections |
| Q28708757 | Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases |
| Q41245978 | Involvement of two microRNAs in the early immune response to DNA vaccination against a fish rhabdovirus |
| Q38212042 | Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages. |
| Q28072142 | Mammalian microRNA: an important modulator of host-pathogen interactions in human viral infections |
| Q28118582 | Mammalian microtubule P-body dynamics are mediated by nesprin-1. |
| Q41097063 | Manipulation of cellular processing bodies and their constituents by viruses. |
| Q38989939 | MiR-506 inhibits PRRSV replication in MARC-145 cells via CD151. |
| Q92511087 | MicroRNA Expression Profiling in Newcastle Disease Virus-Infected DF-1 Cells by Deep Sequencing |
| Q39042688 | MicroRNA Regulation of RNA Virus Replication and Pathogenesis |
| Q55362963 | MicroRNA and cellular targets profiling reveal miR-217 and miR-576-3p as proviral factors during Oropouche infection. |
| Q26798503 | MicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune Response |
| Q33853911 | MicroRNA binding to the HIV-1 Gag protein inhibits Gag assembly and virus production |
| Q49181119 | MicroRNA expression profiling of intestinal mucosa tissue predicts multiple crucial regulatory molecules and signaling pathways for gut barrier dysfunction of AIDS patients |
| Q40312229 | MicroRNA miR-126-5p Enhances the Inflammatory Responses of Monocytes to Lipopolysaccharide Stimulation by Suppressing Cylindromatosis in Chronic HIV-1 Infection |
| Q46187491 | MicroRNA miR-128 represses LINE-1 (L1) retrotransposition by down-regulating the nuclear import factor TNPO1. |
| Q34686537 | MicroRNA miR-320a and miR-140 inhibit mink enteritis virus infection by repression of its receptor, feline transferrin receptor |
| Q38450899 | MicroRNA profile analysis of host cells before and after wild human rotavirus infection |
| Q38563711 | MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV. |
| Q40085833 | MicroRNA-125a-5p Inhibits Cell Proliferation and Induces Apoptosis in Hepatitis B Virus-Related Hepatocellular Carcinoma by Downregulation of ErbB3. |
| Q39037880 | MicroRNA-130a inhibits HCV replication by restoring the innate immune response |
| Q35662247 | MicroRNA-155 Reinforces HIV Latency. |
| Q35108559 | MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients |
| Q35991345 | MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells |
| Q35522595 | MicroRNA-mediated regulation of p21 and TASK1 cellular restriction factors enhances HIV-1 infection |
| Q36404157 | MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. |
| Q35764627 | MicroRNA: implications in HIV, a brief overview |
| Q26773183 | MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations |
| Q36435987 | MicroRNAs and HIV-1: complex interactions |
| Q38116527 | MicroRNAs and bacterial infection. |
| Q35226238 | MicroRNAs and human retroviruses |
| Q37921416 | MicroRNAs and their potential involvement in HIV infection |
| Q34003697 | MicroRNAs are expressed and processed by human primary macrophages |
| Q42321099 | MicroRNAs in HIV-1 infection: an integration of viral and cellular interaction at the genomic level |
| Q27015778 | MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy |
| Q30431405 | Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1). |
| Q35055688 | Mini ways to stop a virus: microRNAs and HIV-1 replication |
| Q30155945 | Modulation of stress granules and P bodies during dicistrovirus infection |
| Q91707903 | Morphine Withdrawal Enhances HIV Infection of Macrophages |
| Q37252567 | Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity. |
| Q36619471 | Movements of HIV-1 genomic RNA-APOBEC3F complexes and PKR reveal cytoplasmic and nuclear PKR defenses and HIV-1 evasion strategies |
| Q47555946 | Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature |
| Q35657666 | Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target |
| Q36576671 | NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression |
| Q36307738 | New insights into HIV assembly and trafficking |
| Q39551817 | P bodies inhibit retrotransposition of endogenous intracisternal a particles |
| Q24611223 | P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages |
| Q39252795 | P-body components LSM1, GW182, DDX3, DDX6 and XRN1 are recruited to WNV replication sites and positively regulate viral replication |
| Q26748918 | Pathogens Use and Abuse MicroRNAs to Deceive the Immune System |
| Q34272358 | Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months |
| Q27014043 | Post-transcriptional regulation of interferons and their signaling pathways |
| Q33611580 | Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection |
| Q34407019 | Profiling microRNAs in lung tissue from pigs infected with Actinobacillus pleuropneumoniae |
| Q42206738 | Proteome analysis of the HIV-1 Gag interactome |
| Q36608205 | RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load |
| Q47565462 | RNA interference-based therapy and its delivery systems |
| Q37346014 | RNA viruses and microRNAs: challenging discoveries for the 21st century. |
| Q28288234 | RNA-based mechanisms regulating host-virus interactions |
| Q37856840 | RNAi and cellular miRNAs in infections by mammalian viruses |
| Q35637946 | Recombinant adeno-associated virus-mediated inhibition of microRNA-21 protects mice against the lethal schistosome infection by repressing both IL-13 and transforming growth factor beta 1 pathways |
| Q35826285 | Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes. |
| Q35799435 | Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients |
| Q35666657 | Replication competent HIV-1 viruses that express intragenomic microRNA reveal discrete RNA-interference mechanisms that affect viral replication |
| Q33900325 | Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs |
| Q42925805 | Reprogramming immune responses via microRNA modulation |
| Q35672257 | Retroviral GAG proteins recruit AGO2 on viral RNAs without affecting RNA accumulation and translation |
| Q35080494 | Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells |
| Q37155048 | SIV replication is directly downregulated by four antiviral miRNAs. |
| Q39326144 | Selective packaging of cellular miRNAs in HIV-1 particles |
| Q36626099 | Sequence requirements for localization and packaging of Ty3 retroelement RNA. |
| Q34723841 | Silencing microRNA by interfering nanoparticles in mice |
| Q37587009 | Small RNA-mediated regulation of host-pathogen interactions |
| Q89603081 | Spatio-temporal characterization of the antiviral activity of the XRN1-DCP1/2 aggregation against cytoplasmic RNA viruses to prevent cell death |
| Q38285749 | Strategies to antagonize miRNA functions in vitro and in vivo |
| Q34087743 | Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells |
| Q30414518 | Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection |
| Q41921194 | The Clinical Application of MicroRNAs in Infectious Disease |
| Q24294522 | The DEAD-box RNA helicase DDX6 is required for efficient encapsidation of a retroviral genome |
| Q36947031 | The Effect of MicroRNA bantam on Baculovirus AcMNPV Infection in Vitro and in Vivo |
| Q34984704 | The HIV-1 Nef protein binds argonaute-2 and functions as a viral suppressor of RNA interference |
| Q39005882 | The HIV-1 Tat protein modulates CD4 expression in human T cells through the induction of miR-222. |
| Q37126033 | The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection |
| Q91785148 | The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29 |
| Q38960851 | The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR. |
| Q30377278 | The emerging role of long non-coding RNAs in HIV infection. |
| Q36478181 | The extent of sequence complementarity correlates with the potency of cellular miRNA-mediated restriction of HIV-1. |
| Q38096026 | The genetic basis of resistance to HIV infection and disease progression |
| Q84589575 | The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ |
| Q34728053 | The microRNA miR-29a is associated with human immunodeficiency virus latency |
| Q90488063 | The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway |
| Q47604571 | The role of miR-29a in HIV-1 replication and latency |
| Q28131796 | The widespread regulation of microRNA biogenesis, function and decay |
| Q38064834 | Tinkering with translation: protein synthesis in virus-infected cells |
| Q26801493 | Translational Control of the HIV Unspliced Genomic RNA |
| Q40951472 | Two cellular microRNAs, miR-196b and miR-1290, contribute to HIV-1 latency |
| Q38215320 | Type I interferons as regulators of human antigen presenting cell functions. |
| Q40129315 | Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection. |
| Q64247484 | Viral Regulation of RNA Granules in Infected Cells |
| Q28543000 | Viral activation of MK2-hsp27-p115RhoGEF-RhoA signaling axis causes cytoskeletal rearrangements, p-body disruption and ARE-mRNA stabilization |
| Q37946208 | Viral subversion of the host protein synthesis machinery |
| Q27028188 | Virus meets host microRNA: the destroyer, the booster, the hijacker |
| Q35263282 | Viruses and microRNAs: RISCy interactions with serious consequences |
| Q36753937 | Viruses, microRNAs, and host interactions |
| Q47548192 | What do we measure when we measure cell-associated HIV RNA. |
| Q26700102 | Who Regulates Whom? An Overview of RNA Granules and Viral Infections |
| Q52641592 | miR-128 inhibits telomerase activity by targeting TERT mRNA. |
| Q36674641 | miR-132 enhances HIV-1 replication |
| Q39408487 | miR-29a associates with viro-immunological markers of HIV infection in treatment experienced patients. |
| Q39352122 | miR-TRAP: a benchtop chemical biology strategy to identify microRNA targets |
| Q42048401 | miRISC recruits decapping factors to miRNA targets to enhance their degradation |
| Q36395827 | miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction |
| Q33763354 | miRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP. |
| Q38114914 | miRNAs and HIV: unforeseen determinants of host-pathogen interaction. |
| Q92878849 | miRNAs and their roles in KSHV pathogenesis |
Search more.